Outsourced Pharma App Notes & Case Studies
-
Overcoming Inventory Challenges For A Complex, Global Study
7/14/2022
Explore how the optimization of Interactive Response Technologies (IRT) settings relieved the burden of managing global supply needs for a CRO customer and clinical sponsor.
-
TFF For Laboratory And Process Development Applications
3/1/2023
Learn about the basic principles that govern tangential flow filtration (TFF) along with the use of TFF capsules and cassettes in laboratory and process development applications.
-
Scale Up Strategy For Oncolytic HSV-1 Vector Manufacturing
3/21/2024
Discover how a novel, large-scale production method for herpes simplex virus type-1 vectors has the potential to accelerate the progress of gene therapy and bring it closer to widespread application.
-
Meeting An Aggressive Go-To-Clinic Timeline
9/27/2023
Finding an outsourcing partner capable of giving your company proper attention and meeting project milestones on schedule is crucial to ensuring patients in need receive treatment in a timely manner.
-
Empty/Full Capsid Ratio Of AAV By Sedimentation Velocity – Analytical Ultracentrifugation
9/29/2022
AAV capsids have the potential to impact safety and efficacy. Here we learn more about the results generated from an internal study using AAV8 capsids.
-
Sterilizing Grade Filter Performance With Biologic Drugs
3/11/2024
Here, we analyze the throughput performance of sterilizing grade filters across moderate-to-high concentrations of mAbs and immunoglobulins and demonstrate how filter selection can impact your process.
-
Solid-State Characterization Of A Small Molecule API
4/10/2024
Ensuring the consistency and purity of the API is paramount when developing a new drug. Learn about the importance of CRO partnerships when facing tight deadlines and complex scientific hurdles.
-
Biacore™ SPR Systems For Titer Analysis Of Adeno-Associated Virus
10/13/2022
We describe the performance of two assays for titer analysis of adeno-associated virus (AAV), serotype 2 and serotype 5, based on surface plasmon resonance (SPR).
-
Getting CMC Right For Emerging Technologies
12/20/2023
Establishing a chemistry, manufacturing, and controls strategy that proves a clinical program is tightly controlled and can address risk is critical to avoiding the pitfalls that stall many promising therapeutics.
-
Overcoming Supply Chain Roadblocks To Ensure Reliable Complex OSD Delivery
2/26/2024
Ensuring critical oral solid dosage (OSD) therapeutics reach patients successfully relies on the ability of developers and manufacturers to navigate the inherent issues surrounding their increasing complexity.